Subtopic Deep Dive

Measurement of Medication Adherence
Research Guide

What is Measurement of Medication Adherence?

Measurement of Medication Adherence involves validated methods including self-report scales, electronic monitoring devices, and pharmacy refill data to quantify patient compliance with prescribed regimens.

Key tools include the Morisky Medication Adherence Scale (MMAS) validated by Morisky et al. (1986, 5242 citations) and the Medication Adherence Rating Scale (MARS) by Thompson et al. (2000, 948 citations). Lam and Fresco (2015, 1226 citations) overview direct and indirect measures across chronic diseases. Over 50 studies since 1986 compare reliability and validity of these approaches.

15
Curated Papers
3
Key Challenges

Why It Matters

Accurate adherence measurement enables evaluation of interventions in hypertension and psychoses, as shown by Morisky et al. (1986) linking self-reports to blood pressure control. Simpson et al. (2006, 1337 citations) meta-analysis ties higher adherence to 24% lower mortality across conditions. Lam and Fresco (2015) highlight nonadherence costs exceeding $100 billion annually in healthcare, underscoring need for reliable metrics in chronic disease management.

Key Research Challenges

Self-Report Overestimation

Patients overreport adherence due to social desirability bias, reducing validity of scales like MMAS (Morisky et al., 1986). Thompson et al. (2000) found MARS improved reliability in psychoses but still showed discrepancies with pill counts. Validating against objective measures remains inconsistent across populations.

Electronic Monitoring Costs

Devices like MEMS caps track openings accurately but face high costs and patient burden (Lam and Fresco, 2015). Adoption limits large-scale studies in primary care. Integration with mHealth shows promise but mixed evidence (Hamine et al., 2015).

Pharmacy Refill Validity

Refill data proxy possession but not ingestion, introducing 'healthy adherer' bias (Simpson et al., 2006). Vermeire et al. (2001, 1824 citations) note variability by disease. Predictive accuracy for outcomes varies widely.

Essential Papers

1.

Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence

Donald E. Morisky, Lawrence W. Green, David M. Levine · 1986 · Medical Care · 5.2K citations

Adherence to the medical regimen continues to rank as a major clinical problem in the management of patients with essential hypertension, as in other conditions treated with drugs and life-style mo...

2.

Patient adherence to treatment: three decades of research. A comprehensive review

Etienne Vermeire, Hilary Hearnshaw, Paul Van Royen et al. · 2001 · Journal of Clinical Pharmacy and Therapeutics · 1.8K citations

Low compliance to prescribed medical interventions is an ever present and complex problem, especially for patients with a chronic illness. With increasing numbers of medications shown to do more go...

3.

A meta-analysis of the association between adherence to drug therapy and mortality

Scot H. Simpson, Dean T. Eurich, Sumit R. Majumdar et al. · 2006 · BMJ · 1.3K citations

Good adherence to drug therapy is associated with positive health outcomes. Moreover, the observed association between good adherence to placebo and mortality supports the existence of the "healthy...

4.

Medication Adherence Measures: An Overview

Wai Yin Lam, Paula Fresco · 2015 · BioMed Research International · 1.2K citations

WHO reported that adherence among patients with chronic diseases averages only 50% in developed countries. This is recognized as a significant public health issue, since medication nonadherence lea...

5.

Impact of mHealth Chronic Disease Management on Treatment Adherence and Patient Outcomes: A Systematic Review

Saee Hamine, Emily Gerth‐Guyette, Dunia Faulx et al. · 2015 · Journal of Medical Internet Research · 1.2K citations

There is potential for mHealth tools to better facilitate adherence to chronic disease management, but the evidence supporting its current effectiveness is mixed. Further research should focus on u...

6.

Understanding Patients’ Adherence-Related Beliefs about Medicines Prescribed for Long-Term Conditions: A Meta-Analytic Review of the Necessity-Concerns Framework

Rob Horne, Sarah Chapman, Rhian Parham et al. · 2013 · PLoS ONE · 1.1K citations

The Necessity-Concerns Framework is a useful conceptual model for understanding patients' perspectives on prescribed medicines. Taking account of patients' necessity beliefs and concerns could enha...

7.

Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses

Katherine Thompson, Jayashri Kulkarni, A.A. Sergejew · 2000 · Schizophrenia Research · 948 citations

Reading Guide

Foundational Papers

Start with Morisky et al. (1986) for MMAS validation in hypertension, then Thompson et al. (2000) for MARS in psychoses, and Vermeire et al. (2001) for three-decade adherence review.

Recent Advances

Lam and Fresco (2015) overview all measures; Cutler et al. (2018, 849 citations) quantify nonadherence economics; Hamine et al. (2015) assess mHealth tools.

Core Methods

Self-reports (MMAS-8, MARS); objective (MEMS, pill counts); proxies (PDC from refills); validated via reliability coefficients and predictive correlations (Morisky et al., 1986; Simpson et al., 2006).

How PapersFlow Helps You Research Measurement of Medication Adherence

Discover & Search

Research Agent uses searchPapers and citationGraph on Morisky et al. (1986) to map 5000+ citing papers, revealing MMAS validations in diabetes. exaSearch queries 'MARS scale psychoses validation' uncovers Thompson et al. (2000) and 200 similar works. findSimilarPapers expands Lam and Fresco (2015) to 50 adherence measure overviews.

Analyze & Verify

Analysis Agent applies readPaperContent to extract psychometric data from Morisky et al. (1986), then verifyResponse with CoVe cross-checks claims against Vermeire et al. (2001). runPythonAnalysis computes meta-analysis effect sizes from Simpson et al. (2006) tables using pandas, with GRADE grading for mortality outcomes.

Synthesize & Write

Synthesis Agent detects gaps like mHealth integration post-Lam and Fresco (2015), flags contradictions in self-report validity. Writing Agent uses latexEditText for methods sections, latexSyncCitations for 20-paper bibliographies, and latexCompile for review manuscripts. exportMermaid visualizes MMAS vs. MARS comparison flowcharts.

Use Cases

"Compare reliability coefficients of MMAS and MARS across studies"

Research Agent → searchPapers + citationGraph → Analysis Agent → runPythonAnalysis (pandas meta-regression on extracted tables) → CSV export of correlation summary statistics.

"Draft LaTeX section on pharmacy refill methods validation"

Research Agent → findSimilarPapers (Lam 2015) → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations + latexCompile → PDF with adherence measure taxonomy figure.

"Find GitHub repos with MMAS implementation code"

Research Agent → paperExtractUrls (Morisky 1986 citers) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for scale scoring.

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers (250+ hits on 'adherence measurement validity') → citationGraph clustering → DeepScan 7-step verification → GRADE-scored report on MMAS predictors. Theorizer generates hypotheses like 'MARS outperforms MMAS in psychoses' from Thompson et al. (2000) + Horne et al. (2013) beliefs data. DeepScan analyzes refill bias with CoVe checkpoints on Simpson et al. (2006).

Frequently Asked Questions

What is the definition of Medication Adherence Measurement?

It quantifies patient compliance using self-reports like MMAS (Morisky et al., 1986), electronic monitors, and refill data.

What are main measurement methods?

Direct methods include pill counts and biomarkers; indirect include self-reports (MMAS, MARS), pharmacy refills (Lam and Fresco, 2015).

What are key papers?

Morisky et al. (1986, 5242 citations) validates MMAS; Thompson et al. (2000, 948 citations) introduces MARS; Simpson et al. (2006) meta-analyzes adherence-mortality links.

What are open problems?

Overcoming self-report bias, reducing electronic monitoring costs, and improving refill ingestion proxies (Vermeire et al., 2001; Lam and Fresco, 2015).

Research Medication Adherence and Compliance with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Measurement of Medication Adherence with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers